Page last updated: 2024-09-03

cholestyramine resin and Hyperlipidemia, Familial Combined

cholestyramine resin has been researched along with Hyperlipidemia, Familial Combined in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19905 (50.00)18.7374
1990's5 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuzawa, Y; Sudo, H; Yamamoto, A; Yamamura, T; Yokoyama, S1
Davignon, J1
Widhalm, K1
Konstantinov, VO; Lipovetskiĭ, BM; Triufanov, VF1
Coates, PM; Cortner, JA; Jarvik, GP; Liacouras, CA2
Coates, PM; Cortner, JA; Gallagher, PR; Liacouras, CA1
Angelin, B; Berglund, L; Ericsson, S; Lindmark, M; Odman, B1
Arai, H; Ishii, K; Kawai, C; Kita, T; Kume, N; Nagano, Y; Otani, H; Ueda, Y; Yokode, M1
Gotto, AM; Jones, PH; Scott, LW1

Reviews

4 review(s) available for cholestyramine resin and Hyperlipidemia, Familial Combined

ArticleYear
[Diagnosis and treatment of primary hyperlipidemias].
    Arquivos brasileiros de cardiologia, 1982, Volume: 38, Issue:1

    Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hyperlipidemia, Familial Combined; Male; Nicotinic Acids; Probucol; Triglycerides

1982
Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
    Current problems in pediatrics, 1994, Volume: 24, Issue:9

    Topics: Adolescent; Adult; Biological Transport; Child; Child, Preschool; Cholestyramine Resin; Diet, Fat-Restricted; Humans; Hyperlipidemia, Familial Combined; Lipoproteins; Lovastatin; Niacin

1994
Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
    The Journal of pediatrics, 1993, Volume: 123, Issue:2

    Topics: Adolescent; Apolipoproteins B; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Genetic Linkage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Lipoproteins, VLDL; Liver; Male; Multigene Family; Niacin; Phenotype; Polymorphism, Genetic; Triglycerides

1993
The diagnosis and management of hyperlipidemia.
    Disease-a-month : DM, 1986, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides

1986

Trials

1 trial(s) available for cholestyramine resin and Hyperlipidemia, Familial Combined

ArticleYear
Gemfibrozil in familial combined hyperlipidaemia: effect of added low-dose cholestyramine on plasma and biliary lipids.
    European journal of clinical investigation, 1991, Volume: 21, Issue:3

    Topics: Adult; Aged; Bile; Cholesterol; Cholestyramine Resin; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Lipid Metabolism; Lipids; Male; Middle Aged

1991

Other Studies

5 other study(ies) available for cholestyramine resin and Hyperlipidemia, Familial Combined

ArticleYear
Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
    International journal of clinical pharmacology, therapy, and toxicology, 1984, Volume: 22, Issue:9

    Topics: Anticholesteremic Agents; Cholestyramine Resin; Drug Therapy, Combination; Female; Heterozygote; Homozygote; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Lipids; Lovastatin; Male; Naphthalenes

1984
[Diagnosis, clinical features and treatment of hyperlipidemias in children].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1982, Volume: 130, Issue:10

    Topics: Adolescent; Arteriosclerosis; Child; Cholestyramine Resin; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Lipoproteins; Risk

1982
[Drug therapy of hyperlipidemic states].
    Klinicheskaia meditsina, 1980, Volume: 58, Issue:4

    Topics: Adolescent; Adult; Cholestyramine Resin; Clofibrate; Drug Evaluation; Female; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Lipids; Male; Middle Aged; Phenotype; Time Factors

1980
Use of cholestyramine in the treatment of children with familial combined hyperlipidemia.
    The Journal of pediatrics, 1993, Volume: 122, Issue:3

    Topics: Adolescent; Apolipoproteins B; Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Follow-Up Studies; Humans; Hyperlipidemia, Familial Combined; Patient Compliance; Triglycerides

1993
Lipoproteins and atherosclerosis.
    Japanese circulation journal, 1990, Volume: 54, Issue:9

    Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholesterol Esters; Cholestyramine Resin; Disease Models, Animal; Foam Cells; Heptanoic Acids; Hyperlipidemia, Familial Combined; Lipoproteins, LDL; Liver; Macrophages; Mice; Naphthalenes; Pravastatin; Probucol; Rabbits; Receptors, Cell Surface; Receptors, Lipoprotein

1990